Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Katharine A Price
Affiliation
Mayo Clinic
ORCID
Career Start Year
2008
Papers
64
H Index
18
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36222355
Adenoid cystic carcinoma of the head and neck: Patterns of recurrence and implications for intensity-modulated radiotherapy.
Head Neck
2023
37734203
Patterns and distribution of regional nodal involvement and recurrence in a surgically treated oropharyngeal squamous cell carcinoma cohort at a tertiary center.
Oral Oncol
2023
35851669
Diagnostic Delay in Human Papillomavirus Negative Oropharyngeal Squamous Cell Carcinoma.
Laryngoscope
2023
37152485
Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter Experience.
Adv Radiat Oncol
2023
37308123
Real-World Implementation of Best-Evidence Cancer Distress Management: Truly Comprehensive Cancer Care.
J Natl Compr Canc Netw
2023
34509079
The role of total parotidectomy in high-grade parotid malignancy: A multisurgeon retrospective review.
Am J Otolaryngol
2022
35420396
Emerging Disparities in Prevention and Survival Outcomes for Patients with Head and Neck Cancer and Recommendations for Health Equity.
Curr Oncol Rep
2022
35777186
Evaluation of pembrolizumab monotherapy in patients with previously treated advanced salivary gland carcinoma in the phase 2 KEYNOTE-158 study.
Eur J Cancer
2022
35867947
Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404).
J Clin Oncol
2022
36129387
Low postoperative lymphocyte count increases risk of progression in human papillomavirus associated oropharyngeal cancer.
Head Neck
2022
35928285
A prospective, randomized trial of patient-reported outcome measures to drive management decisions in hematology and oncology.
Contemp Clin Trials Commun
2022
35157995
Detectable Postoperative Circulating Tumor Human Papillomavirus DNA and Association with Recurrence in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
Int J Radiat Oncol Biol Phys
2022
32969095
Human papillomavirus oropharynx carcinoma: Aggressive de-escalation of adjuvant therapy.
Head Neck
2021
33644935
Survival outcomes in locally advanced cutaneous squamous cell carcinoma presenting with clinical perineural invasion alone.
Head Neck
2021
33752487
Disease Profile and Oncologic Outcomes After Delayed Diagnosis of Human Papillomavirus-Associated Oropharyngeal Cancer.
Otolaryngol Head Neck Surg
2021
34748008
Assessment of Discrimination, Bias, and Inclusion in a United States Hematology and Oncology Fellowship Program.
JAMA Netw Open
2021
34218871
Seeking Joy in Medicine During Uncertain Times: COVID-19 and Social Unrest.
Mayo Clin Proc
2021
34137072
Immune-related hematologic adverse events in the context of immune checkpoint inhibitor therapy.
Am J Hematol
2021
33429428
Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial.
J Natl Cancer Inst
2021
33359567
Costs of Definitive Chemoradiation, Surgery, and Adjuvant Radiation Versus De-Escalated Adjuvant Radiation per MC1273 in HPV+ Cancer of the Oropharynx.
Int J Radiat Oncol Biol Phys
2021
33390298
Yttrium-90 Radioembolization for Treatment of Hepatic Metastasis from Salivary Gland Adenoid Cystic Carcinoma in 4 Patients.
J Vasc Interv Radiol
2021
32663054
Human Papillomavirus-Associated Anogenital Pathology in Females With HPV-Positive Oropharyngeal Squamous Cell Carcinoma.
Otolaryngol Head Neck Surg
2021
32350809
Increased ERBB2 Gene Copy Numbers Reveal a Subset of Salivary Duct Carcinomas with High Densities of Tumor Infiltrating Lymphocytes and PD-L1 Expression.
Head Neck Pathol
2020
32045535
Management of Immune-Related Dermatitis and Mucositis Associated With Pembrolizumab in Metastatic Human Papillomavirus-Associated Squamous Cell Carcinoma of the Oropharynx.
JCO Oncol Pract
2020
33083709
A Rare Case of Prostate-Specific Antigen-Producing Metastatic Parotid Adenocarcinoma Developing Androgen Receptor Resistance.
Mayo Clin Proc Innov Qual Outcomes
2020
32712575
T cell fraction impacts oncologic outcomes in human papillomavirus associated oropharyngeal squamous cell carcinoma.
Oral Oncol
2020
32504888
The prognostic role of medical comorbidities in surgically treated human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Oral Oncol
2020
32213088
Novel Strategies to Effectively De-escalate Curative-Intent Therapy for Patients With HPV-Associated Oropharyngeal Cancer: Current and Future Directions.
Am Soc Clin Oncol Educ Book
2020
30536472
Utility of adjuvant chemotherapy in patients receiving surgery and adjuvant radiotherapy for primary treatment of esthesioneuroblastoma.
Head Neck
2019
31557088
Reply to A.S. Garden.
J Clin Oncol
2019
31428578
First Line Androgen Deprivation Therapy vs. Chemotherapy for Patients With Androgen Receptor Positive Recurrent or Metastatic Salivary Gland Carcinoma-A Retrospective Study.
Front Oncol
2019
31595822
A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer.
Thyroid
2019
31303455
Outcomes following TORS for HPV-positive oropharyngeal carcinoma: PEGs, tracheostomies, and beyond.
Am J Otolaryngol
2019
30706564
Marked responses to pemetrexed chemotherapy for metastatic adenocarcinoma of the parotid gland: Case series.
Head Neck
2019
31163012
Phase II Evaluation of Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus-Associated Oropharynx Squamous Cell Carcinoma.
J Clin Oncol
2019
31021376
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis.
JAMA Oncol
2019
29756250
Esthesioneuroblastoma with distant metastases: Systematic review & meta-analysis.
Head Neck
2018
29909895
Magnitude of benefit for adjuvant radiotherapy following minimally invasive surgery in intermediate to high risk HPV-positive oropharyngeal squamous cell carcinoma.
Oral Oncol
2018
28797445
Characteristics and long-term outcomes of head and neck squamous cell carcinoma after solid organ transplantation.
Oral Oncol
2017
28459738
Integrative medicine in cancer survivors.
Curr Opin Oncol
2017
28878657
Targeted Approaches Applied to Uncommon Diseases: A Case of Salivary Duct Carcinoma Metastatic to the Brain Treated with the Multikinase Inhibitor Neratinib.
Case Rep Oncol
2017
28847412
Relapse Rates With Surgery Alone in Human Papillomavirus-Related Intermediate- and High-Risk Group Oropharynx Squamous Cell Cancer: A Multi-Institutional Review.
Int J Radiat Oncol Biol Phys
2017
27017401
High-grade transformation of acinic cell carcinoma: an inadequately treated entity?
Oral Surg Oral Med Oral Pathol Oral Radiol
2016
31093341
Systemic therapy for recurrent or metastatic salivary gland malignancies.
Cancers Head Neck
2016
26667985
Risk factors for locoregional relapse after transoral robotic surgery for human papillomavirus-related oropharyngeal squamous cell carcinoma.
Head Neck
2016
27418994
Concurrent Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx in a Married Couple.
Case Rep Otolaryngol
2016
25724408
Symptom burden and integrative medicine in cancer survivorship.
Support Care Cancer
2015
25725588
Mechanisms of and therapeutic approaches for overcoming resistance to epidermal growth factor receptor (EGFR)-targeted therapy in squamous cell carcinoma of the head and neck (SCCHN).
Oral Oncol
2015
24467937
Adjuvant chemoradiation therapy with high-dose versus weekly cisplatin for resected, locally-advanced HPV/p16-positive and negative head and neck squamous cell carcinoma.
Oral Oncol
2014
25299140
Nonpharmacologic approach to fatigue in patients with cancer.
Cancer J
2014
1 - 50 of 64
Column Actions
Search
Recommended Authors
Stefano Cavalieri
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, University of Milan
Career Start Year
2016
Number of shared co-authors
4
Ali Hosni
Princess Margaret Cancer Center
Career Start Year
2015
Number of shared co-authors
4
Jennifer Y Y Kwan
Princess Margaret Cancer Centre, University of Toronto
Career Start Year
2013
Number of shared co-authors
1
Soumyajit Roy
Rush University Medical Center
Career Start Year
2013
Number of shared co-authors
1
Melvin L K Chua
National Cancer Centre Singapore
Career Start Year
2011
Number of shared co-authors
8
Chen Hu
Johns Hopkins University School of Medicine
Career Start Year
2009
Number of shared co-authors
2
Farhoud Faraji
University of California San Diego Health
Career Start Year
2008
Number of shared co-authors
2
Julie E Bauman
George Washington University
Career Start Year
2007
Number of shared co-authors
3
Bhumsuk Keam
Seoul National University Hospital
Career Start Year
2006
Number of shared co-authors
2
Shao Hui Huang
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Career Start Year
2004
Number of shared co-authors
9
Robert I Haddad
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year
2001
Number of shared co-authors
9
Sana D Karam
University of Colorado School of Medicine
Career Start Year
2000
Number of shared co-authors
6
Beth M Beadle
Stanford University
Career Start Year
1999
Number of shared co-authors
4
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year
1999
Number of shared co-authors
6
Frank J P Hoebers
Maastricht University Medical Centre
Career Start Year
1999
Number of shared co-authors
9
Patrick K Ha
University of California San Francisco
Career Start Year
1998
Number of shared co-authors
8
Anthony J Cmelak
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year
1997
Number of shared co-authors
4
Lillian L Siu
Princess Margaret Cancer Centre, University Ave
Career Start Year
1995
Number of shared co-authors
5
Stephen Y Lai
The University of Texas MD Anderson Cancer Center
Career Start Year
1995
Number of shared co-authors
2
Cheryl Ho
University of British Columbia
Career Start Year
1995
Number of shared co-authors
3
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Career Start Year
1993
Number of shared co-authors
2
John Waldron
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year
1993
Number of shared co-authors
8
Charles R Thomas
Oregon Health & Science University
Career Start Year
1990
Number of shared co-authors
0
Jeffrey N Myers
The University of Texas MD Anderson Cancer Center
Career Start Year
1988
Number of shared co-authors
8
Ravindra Uppaluri
Brigham and Women's Hospital
Career Start Year
1988
Number of shared co-authors
5
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year
1988
Number of shared co-authors
5
David I Rosenthal
MD Anderson Cancer Center
Career Start Year
1987
Number of shared co-authors
8
Lisa Licitra
Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan
Career Start Year
1987
Number of shared co-authors
8
Wendell G Yarbrough
University of North Carolina at Chapel Hill
Career Start Year
1986
Number of shared co-authors
2
Brian O'Sullivan
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Career Start Year
1982
Number of shared co-authors
13
row(s) 1 - 30 of 30
Collaborators
Robert L Foote
Mayo Clinic
Co-authored papers
23
Daniel J Ma
Mayo Clinic
Co-authored papers
23
Eric J Moore
2Mayo Clinic
Co-authored papers
22
Joaquin J Garcia
Mayo Clinic
Co-authored papers
18
Gregory J Riely
Memorial Sloan Kettering Cancer Center
Co-authored papers
4
Kathryn J Ruddy
Mayo Clinic
Co-authored papers
3
Ezra E W Cohen
university of california san diego Health System
Co-authored papers
2
Vincent A Miller
Injury Prevention Research Center, University of North Carolina
Co-authored papers
2
Luc G T Morris
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
Eric J Sherman
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
Alan L Ho
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
Brent A Bauer
Mayo Clinic
Co-authored papers
2
Nora Katabi
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
David A Palma
University of Western Ontario
Co-authored papers
1
Nancy Y Lee
Memorial Sloan Kettering Cancer Center
Co-authored papers
1
Adriana Salcedo
University of Toronto
Co-authored papers
1
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Co-authored papers
1
Timothy A Chan
Cleveland Clinic.
Co-authored papers
1
Pier Selenica
Memorial Sloan Kettering Cancer Center
Co-authored papers
1
Bert W O'Malley
Center for Coregulator Research, Baylor College of Medicine
Co-authored papers
1
Rama Rao Damerla
Kasturba Medical College, Manipal Academy of Higher Education (MAHE)
Co-authored papers
1
Lydia Y Liu
University of Toronto
Co-authored papers
1
Heiko Sch??der
Memorial Sloan Kettering Cancer Center
Co-authored papers
1
Vaios Hatzoglou
Memorial Sloan Kettering Cancer Center
Co-authored papers
1
Giovanni Motterle
Mayo Clinic
Co-authored papers
1
Rachna Shah
Memorial Sloan Kettering Cancer Center
Co-authored papers
1
Jay O Boyle
Memorial Sloan Kettering Cancer Center
Co-authored papers
1
David G Pfister
Memorial Sloan Kettering Cancer Center
Co-authored papers
1
Carin Y Smith
Division of Clinical Trials and Biostatistics, Mayo Clinic
Co-authored papers
1
Paul C Boutros
University of California los angeles
Co-authored papers
1
1 - 30